![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Diamedica Therapeutics | TSXV:DMA | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.63 | 4.57 | 5.00 | 0 | 01:00:00 |
The following five nominees proposed by the Company were elected as Directors of DiaMedica to serve until the Company’s next Annual General Meeting of Shareholders. The vote results were as follows:
DIRECTOR | VOTES CAST FOR | % OF VOTES CAST FOR | WITHHELD | % WITHHELD | ||
Dr. Michael Giuffre | 56,984,552 | 99.87% | 71,750 | 0.13% | ||
James Parsons | 57,055,102 | 100% | 1,200 | 0% | ||
Rick Pauls | 57,038,252 | 99.97% | 18,050 | 0.03% | ||
Richard Pilnik | 57,045,102 | 99.98% | 11,200 | 0.02% | ||
Zhenyu "Jerry" Xiao | 57,055,102 | 100% | 1,200 | 0% |
DiaMedica shareholders also approved all ballot resolutions, with a minimum of 95.5% of votes cast in favor of each resolution, placed before the meeting and as outlined in the Management Information Circular dated September 30, 2018. The Company’s Management Information Circular is available at www.sedar.com for more details on the matters covered at the meeting. Final voting results on all matters voted on at the meeting will also be filed on SEDAR.
About DiaMedica Therapeutics Inc.
DiaMedica Therapeutics is a clinical stage biopharmaceutical company focused on developing novel treatments for neurological and kidney diseases. DiaMedica’s common shares are listed on the TSX Venture Exchange under the trading symbol “DMA” and quoted on the OTCQB marketplace under the trading symbol “DMCAF”. For more information, please visit www.diamedica.com. Follow us on social media – Twitter, LinkedIn.
For further information, please contact:
Paul Papi Vice President of Business Development DiaMedica Therapeutics Inc. Two Carlson Parkway, Suite 260 Minneapolis, MN Phone: (617) 899-5941 info@diamedica.com
Tweet this!
1 Year DiaMedica Inc. Chart |
1 Month DiaMedica Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions